 |
| Key Conference Highlights: |
|
 |
The latest market trends in recent economy recession from global perspective. The incentive program that Taiwanese government will launch in response to this crisis will be also highlighted and discussed. |
 |
Exploring the trends, paths and approaches to entering China market and elaborate the opportunities in cross strait biotech development. |
 |
The opportunities for the win-win partnerships by pre-screened match making. 2 days of networking opportunities at this Conference. |
 |
The stage to showcase the emerging technologies to potential investors and industry executives |
| July 21 (Tuesday) |
| 08:30 - 09:00 |
Registration |
| 09:00 -
09:30 |
Opening Ceremony
Opening Remarks
on Taiwan's Biotech Development Initiatives |
Session I: Biotech Global Trend
Session Chair: Dr. Chia-Lin Jeff Wang, President, Development Center for Biotechnology |
| 09:30 -
10:05 |
Knowledge Synergies – A New Paradigm of Innovation
Mr. Israel Makov, Chairman, Given Imaging Ltd.
Chairman, Netafim Ltd. |
| 10:05 -
10:30 |
Morning Refreshment & Networking |
| 10:30 -
11:05 |
A Paradigm Shift in Healthcare: Changing Business Models and the Impact of Technology
Ms. Reenita Das, Senior Vice President, Asia Pacific, Healthcare, Frost & Sullivan |
| 11:05 -
11:40 |
The Next Commercial Revolution for Biotechnology
Dr. John Hamer, Managing Director, Burrill & Company |
| 11:40 -
12:15 |
In Search of Innovation in Asia
Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia |
12:15 - 13:45
|
Luncheon
The Current Status and Perspective of Agricultural Technology Licensing in Taiwan
Dr. Tzu-Bin Huang, Director General, Department of Science and Technology, Council of Agriculture, Executive Yuan |
Session II: Investor and Business Partnering
Investor Forum: Exploring Trends, Paths and Opportunities in Greater China
Session Chair: Dr. Marietta Wu, General Manager, Greater China, Burrill & Company |
| 13:45 -
13:50 |
Moderator Remarks and Introduction |
| 13:50 -
14:50 |
| Presentation - Investor perspective with a focus on investing |
| |
Taiwan – A Launch Pad to China and Other Asian Countries
Dr. Marietta Wu, General Manager, Greater China, Burrill & Company
Investment Opportunities in Asia, Particularly in China and Taiwan
Dr. Nancy Chang, Chairman and Senior Managing Director, Asia, OrbiMed
Adivosors
Life Science Venture Investment and Partnering Opportunities in China
Dr. Frank Kung, Managing Partner, Vivo Ventures
General Introduction of IP Status in China; Impact of Change of the Law;
China Related Issues on Investing and Licensing(TBD)
Dr. James Zhu, Beijing Managing Partner, Perkins Coie LLP |
|
| 14:50 -
15:20 |
| Presentation - Company perspective with a focus on partnership |
| |
Maintaining a Competitive Edge via Partnering in a Changing Landscape
Dr. Jennifer Hu, Director, Licensing & External Research, Merck Sharp & Dohme
Partnership Strategy for Asian Biotech
Mr. George Yeh, President, Taiwan Liposome Company Ltd.
|
|
| 15:20 -
15:50 |
Networking Refreshment Break & Exhibition |
| 15:50 -
17:20 |
| Panel Discussion |
| |
Elaborate the opportunities in cross strait biotech development
Discuss and analyze the latest trends in partnering and provide insights into
successful alliance formation
Provide a successful approach to enter this dynamic market |
|
| 17:20 -
18:00 |
Cocktail Reception & Exhibition |
| 18:00 |
Dinner Banquet |
| July 22 (Wednesday) |
Session III:Successful Business Model and Strategy
Session Chair: Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia |
| 09:00 -
09:10 |
Moderator Remarks and Introduction |
| 09:10 - 09:30 |
From the Bench to the Bedside
Dr. Dalia Cohen, Chief Scientific Officer, Rosetta Genomics |
| 09:30 -
09:50 |
Global Strategic Alliances: a Start-up's Perspective
Dr. Ming-Chu Hsu, Chairman and CEO, TaiGen Biotechnology Co., Ltd. |
| 09:50 -
10:10 |
The Road from NIH SBIR Grants to a Therapeutic Antibody Company
Dr. Jeng Her, CEO, Protevo Biotech |
| 10:10 -
10:30 |
Morning Refreshment & Networking |
| 10:30 -
10:50 |
Global Strategic Alliance - A Venture Capitalist's Perspective
Mr. Antony Paul Bishop, Council member, New Zealand Venture Capital Association |
| 10:50 -
12:00 |
| Panel Discussion: Innovative Business Models in Biotech Industry to Overcome the Recent Economic Recession |
|
| Moderator: |
| Dr. Dalia Cohen, Chief Scientific Officer, Rosetta Genomics |
|
| Panelists: |
| Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia |
Dr. Ming-Chu Hsu, Chairman and CEO, TaiGen Biotechnology Co., Ltd.
|
| Dr. Jeng Her, CEO, Protevo Biotech |
| Mr. Antony Paul Bishop, Council member, New Zealand Venture Capital Association |
| Dr. Axel Polack, General Partner, TVM Capital |
| Mr. Tomas Landh, Director Strategy and Sourcing, Diabetes Research Unit, Novo Nordisk A/S |
|
| 12:00 -
13:30 |
Luncheon: Country Highlight
National Policy: Catalyst to Thailand's Biotechnology Industry
Prof. Dr. Morakot Tanticharoen, Vice President of NSTDA and Senior Advisor to BIOTEC |
| Session IV: Business-to-Business Partnering |
| 13:30 -
16:30 |
Company Presentation - Biotech Investment Opportunities
24 biotech companies from USA, Germany, Austria, Taiwan, China, Netherlands, Thailand, Denmark, etc. will present their Corporate and R&D overview. It is a supreme opportunity for biotech companies, the major VC's, and investors from all over the world to meet one on one. |
| 16:30 -
17:30 |
One-on-One Meetings |
| 17:30 |
Adjournment |
|